Sanofi: all 2,424 studies
Page 13 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney TransplantCompletedNCT03099122Phase 4
- A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)CompletedNCT03096080Phase 1
- Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female SubjectsCompletedNCT03070678Phase 1
- PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult SubjectsCompletedNCT03069963Phase 1
- Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult SubjectsCompletedNCT03065816Phase 1
- Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of SotagliflozinCompletedNCT03063580Phase 1
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese SubjectsCompletedNCT02979015Phase 1
- A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCompletedNCT02977533Phase 1
- Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentCompletedNCT02967237Phase 4
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCompletedNCT02967224Phase 4
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompletedNCT02967211Phase 4
- A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyCompletedNCT02954692Phase 4
- Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue VaccineCompletedNCT02948933
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanCompletedNCT02941367Phase 4
- A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and MetoprololCompletedNCT02940379Phase 1
- Postmarketing Surveillance Study for IMOJEV® in Republic of KoreaCompletedNCT02933710
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedNCT02910518Phase 1
- Postmarketing Surveillance Study for Use of Menactra® in the Republic of KoreaCompletedNCT02864927Phase 4
- Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic TherapyCompletedNCT02855684Phase 3
- Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the KneeCompletedNCT02845271Phase 2
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionActive, not recruitingNCT02843035Phase 2
- Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedNCT02842359Phase 4
- Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)CompletedNCT02836704Phase 4
- Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue VaccineCompletedNCT02827162
- DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected InfantsCompletedNCT02817451Phase 3
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02803918Phase 1
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCompletedNCT02752828Phase 3
- Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsCompletedNCT02752412Phase 3
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCompletedNCT02749890Phase 3
- Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT02713477Phase 1
- Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian FederationCompletedNCT02699840
- Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.CompletedNCT02697474Phase 3
- Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWithdrawnNCT02667496Phase 2
- Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerCompletedNCT02664103Phase 2
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced HypoglycemiaWithdrawnNCT02635243Phase 1
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus PatientsCompletedNCT02625636Phase 1
- Mast Cell Connect: A Registry for Patients With MastocytosisCompletedNCT02620254
- Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101TerminatedNCT02616055Phase 2
- Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeCompletedNCT02610348Not applicable
- A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial CarcinomaTerminatedNCT02608125Phase 1
- Treatment of Type 2 Diabetes With Long Acting Basal Insulin in JordanCompletedNCT02606357Phase 4
- Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin InfusionCompletedNCT02603510Phase 1
- Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using ToujeoCompletedNCT02585674Phase 3
- A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisCompletedNCT02583594Phase 1
- A Study of SAR428926 in Patients With Advanced Solid TumorsCompletedNCT02575781Phase 1
- (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid MalignanciesCompletedNCT02561988Phase 1
- Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy RegistryCompletedNCT02554409
- A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and OlderCompletedNCT02553343Phase 2
- Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)CompletedNCT02545842Phase 4
- A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCompletedNCT02536937Phase 1
- A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCompletedNCT02536911Phase 1
- 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02531152Phase 1
- Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous LeukemiaWithdrawnNCT02520102Phase 2
- Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver DiseasesCompletedNCT02517385Phase 3
- A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple MyelomaCompletedNCT02514668Phase 1
- Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate TransplantationCompletedNCT02513186Phase 1
- A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular CarcinomaCompletedNCT02508467Phase 1
- Efficacy and Tolerability Study of Avanafil in RussiaCompletedNCT02503306Phase 3
- Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated DisordersCompletedNCT02502903Phase 1
- Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell DiseaseCompletedNCT02447627
- Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate CancerCompletedNCT02441894Phase 4
- A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET AmplificationCompletedNCT02435121Phase 2
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompletedNCT02434822Phase 3
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCompletedNCT02428491Phase 3
- First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the KneeCompletedNCT02424942Phase 1
- Taste Evaluation of Different Liquid Formulations With EliglustatCompletedNCT02422654Phase 1
- Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCompletedNCT02411825Phase 1
- Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT02404558Phase 1
- Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus PatientsCompletedNCT02401243Phase 3
- A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic RhinitisCompletedNCT02401191Phase 3
- Fc factOrs and Real-World hemophiliA Patient-ReporteD OutcomesTerminatedNCT02392156
- Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT02343926Phase 3
- An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD PatientsCompletedNCT02332811Phase 3
- Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired PneumoniaTerminatedNCT02332577Phase 4
- Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female PatientsWithdrawnNCT02331810Phase 1
- Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female PatientsCompletedNCT02321709Phase 1
- A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668CompletedNCT02313285
- A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171CompletedNCT02309320Phase 1/2
- Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839TerminatedNCT02306811Phase 2
- SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM PatientsCompletedNCT02283775Phase 1
- A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCompletedNCT02282826Phase 1
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic PatientsTerminatedNCT02274740Phase 2
- DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCompletedNCT02274285Phase 3
- A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 DiabetesCompletedNCT02273258Phase 1
- Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)CompletedNCT02241057Not applicable
- Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DMCompletedNCT02227212Phase 3
- Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple SclerosisTerminatedNCT02222948Phase 2
- Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin LymphomaCompletedNCT02221492Phase 2
- Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple MyelomaCompletedNCT02221479Phase 2
- Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADACompletedNCT02205489Phase 4
- Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With LantusCompletedNCT02201199Phase 1
- TOFO Insulin Combination TrialCompletedNCT02201004Phase 4
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin GlargineCompletedNCT02200991Phase 4
- Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.CompletedNCT02189733Phase 1
- Evaluation of SAR408701 in Patients With Advanced Solid TumorsTerminatedNCT02187848Phase 1
- Evaluation of Efficacy of Dellegra in Exposure UnitCompletedNCT02175485Phase 4
- Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American ChildrenCompletedNCT02169817Phase 4
- ATHENA: Natural History of Disease Study in Alport Syndrome PatientsCompletedNCT02136862
- CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical PracticeCompletedNCT02109250
- ALX-0061 Phase I Bioavailability Study in Healthy VolunteersCompletedNCT02101073Phase 1